MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 118 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $33,000 | -98.6% | 26,500 | -96.6% | 0.00% | -100.0% |
| Q1 2017 | $2,415,000 | -38.8% | 784,174 | -18.9% | 0.01% | -42.1% |
| Q4 2016 | $3,946,000 | -34.5% | 967,218 | +1.9% | 0.02% | -26.9% |
| Q3 2016 | $6,025,000 | +17.9% | 948,827 | +0.1% | 0.03% | +13.0% |
| Q2 2016 | $5,111,000 | +46.1% | 948,279 | +126.9% | 0.02% | +43.8% |
| Q1 2016 | $3,498,000 | +4.3% | 417,943 | -1.6% | 0.02% | +6.7% |
| Q4 2015 | $3,355,000 | -9.1% | 424,695 | -2.1% | 0.02% | 0.0% |
| Q3 2015 | $3,690,000 | -32.6% | 433,622 | -2.1% | 0.02% | -31.8% |
| Q2 2015 | $5,475,000 | +4.1% | 442,795 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $5,260,000 | +181.0% | 442,795 | +167.3% | 0.02% | +175.0% |
| Q4 2014 | $1,872,000 | – | 165,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |